GO
Loading...

Biogen Idec and Isis form strategic alliance

Monday, 9 Sep 2013 | 8:40 AM ET

Stanley Crooke, Isis Pharmaceuticals chairman & CEO, discusses his company's strategic new partnership in the treatment of neurological disorders using antisense therapy.